ANIX
ANIX
Positions held
Your positionsANIX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
2026-09-16 · Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
2026-09-03 · Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
2026-08-18 · Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-07-22 · Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know
2026-07-22 · New Strong Buy Stocks for July 22nd
Price (daily)
Full chart · RSI · MACD · patterns